In gliomas, miR-1224-3p was inhibited by EZH2, which in turn regulated β-catenin expression through binding to its 3′UTR, thus controlling proliferation, invasion, and glucose metabolism of cells (23). This evidence concerns the gene EZH2 and central nervous system cancer.